Pilot Plan for Data Collection Tools for the Interim Local Health Department Strategy for Response, Control, and Prevention of Healthcare Associated Infections (HAI) and Antibiotic Resistance (AR)

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

June 17, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services, as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Pilot Plan for the Interim Local Health Department Strategy for Response, Control, and Prevention of Healthcare Associated Infections (HAI) and Antibiotic Resistance (AR). The proposed collection is designed to strengthen local and regional capacity to respond to, control, and prevent HAI/AR across all healthcare settings and in the community by supporting enhanced coordination between state and local partners and by promoting local public health, healthcare, and community partner networks.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 117 (Friday, June 17, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 117 (Friday, June 17, 2022)]
[Notices]
[Pages 36504-36505]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-13095]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-22GG; Docket No. CDC-2022-0077]

Pilot Plan for Data Collection Tools for the Interim Local Health
Department Strategy for Response, Control, and Prevention of Healthcare
Associated Infections (HAI) and Antibiotic Resistance (AR)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services, as part of its
continuing effort to reduce public burden and maximize the utility of
government information, invites the general public and other Federal
agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Pilot Plan for the Interim Local Health Department Strategy for
Response, Control, and Prevention of Healthcare Associated Infections
(HAI) and Antibiotic Resistance (AR). The proposed collection is
designed to strengthen local and regional capacity to respond to,
control, and prevent HAI/AR across all healthcare settings and in the
community by supporting enhanced coordination between state and local
partners and by promoting local public health, healthcare, and
community partner networks.

DATES: CDC must receive written comments on or before August 16, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0077, by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#6807050a280b0c0b460f071e"><span class="__cf_email__" data-cfemail="3e51535c7e5d5a5d10595148">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;

[[Page 36505]]

3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.

Proposed Project

Pilot Plan for the Interim Local Health Department Strategy for
Response, Control, and Prevention of Healthcare Associated Infections
(HAI) and Antibiotic Resistance (AR)--New--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).

Background and Brief Description

The Centers for Disease Control and Prevention (CDC) Division of
Healthcare Quality Promotion (DHQP) recently developed an Interim Local
Health Department Strategy for Response, Control, and Prevention of
Healthcare Associated Infections (HAI) and Antibiotic Resistance (AR).
CDC's vision is to strengthen local and regional capacity to respond
to, control, and prevent HAI/AR across all healthcare settings and in
the community by supporting enhanced coordination between state and
local partners and by promoting local public health, healthcare, and
community partner networks. This vision can be achieved with
collaboration between local, state, and federal public health entities,
and partners. This strategy aims to strengthen local health departments
(LHD) by focusing on three main goals: (1) growing strong partner
networks; (2) building internal operational capacity; and (3) expanding
the scope of programmatic activities to effectively address HAI/AR in
their jurisdictions.
CDC's next steps include piloting the strategy with local health
departments in part through a cooperative agreement with the National
Association for County and City Health Officials (NACCHO) and is
proposing this data collection to gather information from LHDs during
that pilot phase. The strategy was developed to highlight and support
the important role LHDs play in preventing, responding to, and
controlling HAI and AR related events. The HAI/AR activities that are
conducted by LHDs vary widely and depend on many factors such as staff
capacity and expertise, governance structures and public health
authorities, prevalence of emerging HAI/AR diseases, types, and
organization of healthcare facilities in the jurisdiction, population
demographics, local relationships, and nature of collaborations with
the state HAI/AR program. While the specific activities and
responsibilities of LHDs will vary, the unique roles and assets of LHDs
make them critical players in the prevention and control of HAI/AR
infections. LHDs can build relationships in their local communities and
may be well-positioned to understand and respond to the health needs of
their communities. There is much to be learned and many best practices
to be shared from LHD working in HAI/AR. Engaging with LHDs is
essential for DHQP to connect to other priority areas such as focusing
on rural areas, healthcare preparedness, and health equity
considerations. Additionally, a local engagement strategy will help
DHQP expand their activities to focus on connecting with LHDs that
directly work between healthcare and public health groups, especially
to continue work and partnerships begun by COVID-19 task forces.
The data collection and subsequent data analysis will identify
themes and commonalities that will be used to make updates to the
strategy and identify areas of support for LHDs seeking to grow their
capacity for HAI/AR activities. CDC requests OMB approval for an
estimated 390 annual burden hours. There are no costs to respondents
other than their time to participate.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in hours (in
respondent hours) hours)
----------------------------------------------------------------------------------------------------------------
Voluntary LHD Participants.... LHD HAI/AR 30 1 4 120
Strategy Pilot
Feedback Form.
Voluntary LHD Participants.... LHD HAI/AR 30 1 1 30
Strategy Pilot
Interview Guide
Survey.
Voluntary LHD Participants.... LHD HAI/AR 30 1 2 60
Strategy Pilot
Survey for
Review and
Implement.
NACCHO CoAg LHD Participants.. LHD HAI/AR 30 1 2 60
Strategy Pilot
Survey.
NACCHO CoAg LHD Participants.. LHD HAI/AR 30 1 4 120
Strategy Pilot
Feedback Form.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 390
----------------------------------------------------------------------------------------------------------------

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-13095 Filed 6-16-22; 8:45 am]
BILLING CODE 4163-18-P

</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on June 17, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.